Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy.
Eva HollemansEsther I VerhoefChris H BangmaJohn RietbergenMonique J RoobolJozien HellemanG J L H Geert van LeendersPublished in: Histopathology (2021)
In conclusion, patients with GG2- prostate cancer at radical prostatectomy have more advanced disease and shorter biochemical recurrence-free survival than those with GG1 prostate cancer, but both groups have a very low risk of developing metastasis.